Current state and future prospects of pharmacological interventions for autism

被引：2

作者：

Vahabzadeh, Arshya ^{[1
]}

Buxton, David ^{[2
]}

McDougle, Christopher J. ^{[3
,4
]}

Stigler, Kimberly A. ^{[5
,6
]}

机构：

[1] Emory Univ, Sch Med, Dept Psychiat & Behav Sci, Atlanta, GA USA

[2] Harvard Univ, Sch Med, Dept Psychiat, Massachusetts Gen Hosp, Boston, MA 02115 USA

[3] Harvard Univ, Sch Med, Dept Psychiat, Boston, MA 02115 USA

[4] Massachusetts Gen Hosp, Lurie Ctr Autism, Boston, MA 02114 USA

[5] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN USA

[6] James Whitcomb Riley Hosp Children, Indianapolis, IN 46202 USA

来源：

NEUROPSYCHIATRY | 2013年 / 3卷 / 02期

关键词：

PERVASIVE DEVELOPMENTAL DISORDERS; OPEN-LABEL TRIAL; PLACEBO-CONTROLLED TRIAL; DEFICIT HYPERACTIVITY DISORDER; PSYCHOTROPIC MEDICATION USE; SELF-INJURIOUS-BEHAVIOR; SPECTRUM DISORDERS; DOUBLE-BLIND; D-CYCLOSERINE; YOUNG-ADULTS;

D O I：

10.2217/NPY.13.22

中图分类号：

Q189 [神经科学];

学科分类号：

071006 ;

摘要：

Autism spectrum disorder (ASD) is a group of heterogeneous developmental disorders manifesting in early childhood. They are associated with a range of core and associated symptoms, including repetitive behaviors, hyperactivity and irritability. This review will describe the current evidence for psychopharmacological management of individuals with ASD. Additionally, some of the future treatment prospects will be discussed. Safety issues, adverse effects and limitations of the current literature will also be highlighted.

引用

页码：245 / 259

页数：15

共 95 条

[1] Double-blind placebo-controlled trial of pentoxifylline added to risperidone: Effects on aberrant behavior in children with autism [J].

Akhondzadeh, Shahin ;

Fallah, Jalil ;

Mohammadi, Mohammad-Reza ;

Imani, Reza ;

Mohammadi, Mohammad ;

Salehi, Bahman ;

Ghanizadeh, Ahmad ;

Raznahan, Maedeh ;

Mohebbi-Rasa, Soodeh ;

Rezazadeh, Shams-Ali ;

Forghani, Saeedeh .

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2010, 34 (01) :32-36

[2] Acute and long-term safety and tolerability of risperidone in children with autism [J].

Aman, MG ;

Arnold, LE ;

McDougle, CJ ;

Vitiello, B ;

Scahill, L ;

Davies, M ;

McCracken, JT ;

Tierney, E ;

Nash, PL ;

Posey, DJ ;

Chuang, S ;

Martin, A ;

Shah, B ;

Gonzalez, NM ;

Swiezy, NB ;

Ritz, L ;

Koenig, K ;

McGough, J ;

Ghuman, JK ;

Lindsay, RL .

JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 2005, 15 (06) :869-884

[3]

AMAN MG, 1995, AM J MENT RETARD, V100, P283

[4]

[Anonymous], 2000, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890425787

[5] Retrospective Review of Clozapine in the Treatment of Patients With Autism Spectrum Disorder and Severe Disruptive Behaviors [J].

Beherec, Laurene ;

Lambrey, Simon ;

Quilici, Gwendoline ;

Rosier, Antoine ;

Falissard, Bruno ;

Guillin, Olivier .

JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2011, 31 (03) :341-344

[6] Lamotrigine therapy for autistic disorder: A randomized, double-blind, placebo-controlled trial [J].

Belsito, KM ;

Law, PA ;

Kirk, KS ;

Landa, RJ ;

Zimmerman, AW .

JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 2001, 31 (02) :175-181

[7] Clomipramine in adults with pervasive developmental disorders: A prospective open-label investigation [J].

Brodkin, ES ;

McDougle, CJ ;

Naylor, ST ;

Cohen, DJ ;

Price, LH .

JOURNAL OF CHILD AND ADOLESCENT PSYCHOPHARMACOLOGY, 1997, 7 (02) :109-121

[8] COMPARISON OF HALOPERIDOL AND BEHAVIOR-THERAPY AND THEIR INTERACTION IN AUTISTIC-CHILDREN [J].

CAMPBELL, M ;

ANDERSON, LT ;

MEIER, M ;

COHEN, IL ;

SMALL, AM ;

SAMIT, C ;

SACHAR, EJ .

JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1978, 17 (04) :640-655

[9] Neuroleptic-related dyskinesias in autistic children: A prospective, longitudinal study [J].

Campbell, M ;

Armenteros, JL ;

Malone, RP ;

Adams, PB ;

Eisenberg, ZW ;

Overall, JE .

JOURNAL OF THE AMERICAN ACADEMY OF CHILD AND ADOLESCENT PSYCHIATRY, 1997, 36 (06) :835-843

[10] Low-dose venlafaxine in three adolescents and young adults with autistic disorder improves self-injurious behavior and attention deficit/hyperactivity disorders (ADHD)-like symptoms [J].

Carminati, GG ;

Deriaz, N ;

Bertschy, G .

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2006, 30 (02) :312-315

← 1 2 3 4 5 6 7 8 9 10 →